Pharma Two B Competitors and Similar CompaniesClear all
Clovis Oncology's competitors and similar companies include Exelixis and Verastem Oncology.
 Clovis Oncology Clovis Oncology is a biopharmaceutical company focused on acquiring, developing and commercializing anti-cancer agents. |  Verastem Oncology Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. | ||
Founding Date | Founding Date 2009 | Founding Date 1994 | Founding Date 2010 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Alameda, US HQ | Locations Needham, US HQ Walsrode, DE | |
Employees | Employees 4843% increase | Employees 1,14712% decrease | Employees 7328% increase |
Valuation ($) | Valuation ($) 10.6 m | Valuation ($) 8.2 b | Valuation ($) 144.9 m |
Financial | |||
Revenue (est.) | Revenue (est.) $148.8m (FY, 2021) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) $30.9m (FY, 2025) |
Net income | Net income ($264.5m) (FY, 2021) | Net income $782.6m (FY, 2025) | Net income ($209.5m) (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 357m | Total funding raised N/A | Total funding raised $ 170m |
For sources of this data, please see the company profile
View Company Profiles
Exelixis
HQ
Alameda, US
Employees
1,147↓ 12% decrease
Exelixis is an oncology company that develops cancer treatments.
View companyVerastem Oncology
HQ
Needham, US
Employees
73↑ 28% increase
Verastem Oncology is a biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer.
View company